| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |